Type
Internal restructuring
Country
Germany
Region
Hessen; Gießen; Marburg-Biedenkopf
Location of affected unit(s)
Marburg
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.1 - Manufacture of basic pharmaceutical products

270 jobs
Number of planned job losses
Job loss
Announcement Date
3 December 2015
Employment effect (start)
3 December 2015
Foreseen end date
31 December 2017

Description

UK-based pharmaceuticals company GlaxoSmithKline's (GSK) will cut 1,500 out of 15,500 jobs worldwide by the end of 2017 including 270 jobs in Germany. The company announced that 270 out of 1,230 jobs will be cut at its production site in Marburg. This represents 20% of all full time jobs at this site. According to the company, this is due to the integration of the vaccine range of its Swiss competitor Novartis into its portfolio which became necessary due to a previous business transfer. The job cuts form part of a wider austerity programme within the GSK group.

GlaxoSmithKline (GSK) is a British multinational pharmaceutical company headquartered in Brentford, London. The company has a total of 5 sites in Germany.  Currently, the company employs 15,500 staff worldwide.


Sources

  • 3 December 2015: Focus Online
  • 2 December 2015: Hinterländer Anzeiger Online

Citation

Eurofound (2015), GlaxoSmithKline (GSK), Internal restructuring in Germany, factsheet number 86012, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/86012.